Binding of amino acid side-chains to S1 cavities of serine proteinases

Journal of Molecular Biology

Volumn 266, Issue 2, 1997, Pages 441-461

  Lu, Wuyuan ^a   Apostol, Izydor ^a   Qasim, M A ^a   Warne, Nicholas ^a   Wynn, Richard ^a   Zhang, Wen Lei ^a   Anderson, Stephen ^b   Chiang, Yi Wen ^b   Ogin, Eleanor ^b   Rothberg, Irvin ^b   Ryan, Kevin ^b   Laskowski Jr, Michael ^a  

^a PURDUE UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Amino acid side chains, binding of; Equilibrium constants for association; Protein protein interaction; Proteinase inhibitors; Serine proteinases

Indexed keywords

ASPARTIC ACID; CHYMOTRYPSIN; GLUTAMIC ACID; ISOLEUCINE; LEUKOCYTE ELASTASE; PANCREATIC ELASTASE; PROLINE; PROTEINASE; PROTEINASE INHIBITOR; SERINE; SERINE PROTEINASE; SUBTILISIN; VALINE;

AMINO ACID SEQUENCE; ARTICLE; CALCULATION; CATTLE; CONTROLLED STUDY; ENZYME BINDING; ENZYME INHIBITOR COMPLEX; ENZYME SPECIFICITY; EQUILIBRIUM CONSTANT; EVOLUTION; GENETIC ENGINEERING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; RECOMBINANT DNA TECHNOLOGY; STREPTOMYCES GRISEUS; SWINE; TURKEY (BIRD);

AVES; BOS TAURUS; BOVINAE; MELEAGRIS GALLOPAVO; STREPTOMYCES GRISEUS; SUIDAE; SUS SCROFA;

EID: 0031581824     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0781     Document Type: Article

References (100)

1. Anfinsen C. B., Corley L. G. An active variant of staphylococcal nuclease containing norleucine in place of methionine. J. Biol. Chem. 244:1969;5149-5152.
2. Apostol, I. Komiyama, T. Yoshida, N. Laskowski, M, Jr, 1991, Glu specific Streptomyces griseus proteinase-Glu SGP- is homologous to SGPA, SGPB and α lytic proteinase.
3. Apostol I., Giletto A., Komiyama T., Zhang W., Laskowski M., Jr. Amino acid sequences of ovomucoid third domains from 27 additional species of birds. J. Protein Chem. 12:1993;419-433.
4. Ardelt W., Laskowski M., Jr. Analytical ion exchange chromatography of proteins. Anal. Biochem. 120:1982;198-203.
5. Ardelt W., Laskowski M., Jr. Effect of single amino acid replacements on the thermodynamics of the reactive site peptide bond hydrolysis in ovomucoid third domain. J. Mol. Biol. 220:1991;1041-1053.
6. 1variants of OMTKY3.
7. Bauer C.-A. Active centers of Streptomyces griseus Protease 1, Streptomyces griseus Protease 3, and α-chymotrypsin: Enzyme-substrate interactions. Biochemistry. 17:1978;375-380.
8. Beckmann J., Mehlich A., Schröder W., Wenzel H. R., Tschesche H. Preparation of chemically "mutated" aprotinin homologues by semisynthesis. Eur. J. Biochem. 176:1988;675-682.
9. 15-aprotinin involving enzymatic peptide bond resynthesis. J. Protein Chem. 8:1989;101-113.
10. Bigler, T. 1991, Semisynthesis of ovomucoid third domain variants: structure-function studies. PhD thesis, Purdue University, West Lafayette, IN, USA.
11. 1residues. Protein Sci. 2:1993;786-799.
12. Bode W., Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Eur J. Biochem. 204:1992;433-451.
13. Bode W., Epp O., Huber R., Laskowski M., Jr, Ardelt W. The crystal and molecular structure of the third domain of silver pheasant ovomucoid (OMSVP3). Eur. J. Biochem. 147:1985;387-395.
14. Bode W., Wei A.-Z., Huber R., Meyer E., Travis J., Neumann S. X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J. 5:1986;2453-2458.
15. Bode W., Meyer E., Powers J. C. Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors. Biochemistry. 28:1989;1951-1963.
16. 162polymorphism in Japanese quail ovomucoid. J. Biol. Chem. 255:1980;6569-6574.
17. Born M. Volumen und hydralabonswärme der ionen. Z. Phys. 1:1920;45-49.
18. Campbell R. C. Statistics for Biologists. 1989;Cambridge University Press.
19. Clackson T., Wells J. A. A hot spot of binding energy in a hormone receptor interface. Science. 267:1995;383-386.
20. Creighton T. E., Darby N. J. Functional evolutionary divergence of proteolytic enzymes and their inhibitors. Trends Biochem. Sci. 14:1989;319-324.
21. Cunningham B. C., Wells J. A. High resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science. 244:1989;1081-1085.
22. Doig A. J., Sternberg M. J. E. Side-chain conformational entropy in protein folding. Protein Sci. 4:1995;2247-2251.
23. Dorovska V. N., Varfolomeyev S. D., Kazanskaya N. F., Klyosov A. A., Martinek K. The influence of the geometric properties of the active centre on the specificity of α-chymotrypsin catalysis. FEBS Letters. 23:1972;122-124.
24. Eisenberg S. P., Hale K. K., Heimdal P., Thompson R. C. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J. Biol. Chem. 265:1990;7976-7981.
25. Empie M. W., Laskowski M., Jr. Thermodynamics and kinetics of single residue replacements in avian ovomucoid third domains: Effect on inhibitor interactions with serine proteinases. Biochemistry. 21:1982;2274-2284.
26. Eriksson A. E., Baase W. A., Zhang X.-J., Heinz D. W., Blaber M., Baldwin E. P., Matthews B. W. Response of a protein structure to cavity-creating mutations and its relation to the hydrophobic effect. Science. 255:1992;178-183.
27. Fersht A. R. Enzyme Structure and Mechanism. 1977;W. H. Freeman and CompanyReading & Sons, San Francisco.
28. Fersht A. R. Enzyme Structure and Mechanism. 1985;W. H. Freeman and CompanyReading & Sons, San Francisco.
29. Fujinaga M., Read R. J., Sielecki A., Ardelt W., Laskowski M., Jr, James M. N. G. Refined crystal structure of the molecular complex of Streptomyces griseus protease B, a serine protease, with the third domain of the ovomucoid inhibitor from turkey. Proc. Natl Acad. Sci. USA. 79:1982;4868-4872.
30. Fujinaga M., Delbaere L. T. J., Brayer G. D., James M. N. G. Refined structure of α-lytic protease at 1.7 Å resolution analysis of hydrogen bonding and solvent structure. J. Mol. Biol. 183:1985;479-502.
31. Fujinaga M., Sielecki A. R., Read R. J., Ardelt W., Laskowski M., Jr, James M. N. G. Crystal and molecular structures of the complex of α-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 Å resolutions. J. Mol. Biol. 195:1987;397-418.
32. Green N. M., Work E. Pancreatic trypsin inhibitor. Biochem. J. 54:1953;347-352.
33. Grøn H., Meldal M., Breddam K. Extensive comparison of the substrate preferences of two subtilisins as determined with peptide substrates which are based on the principle of intramolecular quenching. Biochemistry. 31:1992;6011-6018.
34. Hansch C., Coats E. α-Chymotrypsin: a case study of substituent constants and regression analysis in enzymic structure-activity relationships. J. Pharm. Sci. 59:1970;731-743.
35. α, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates. Biochemistry. 23:1984;2995-3002.
36. Henderson G., Krygsman P., Liu C. J., Davey C. C., Malek L. T. Characterization and structure of genes for proteases A and B from Streptomyces griseus. J. Bacteriol. 169:1987;3778-3784.
37. Horovitz A., Serrano L., Fersht A. R. COSMIC analysis of the major α-helix of barnase during folding. J. Mol. Biol. 219:1991;5-9.
38. Huang, K. 1995, Structural studies of the interactions between serine proteinases and protein inhibitors. Ph.D. thesis, University of Alberta, Edmonton, Alberta, Canada.
39. 18variants of turkey ovomucoid inhibitor third domain with Streptomyces griseus proteinase B. Protein Sci. 4:1995;1985-1997.
40. Janoff A., Basch R. S. Further studies on elastase-like esterases in human leukocyte granules. Proc. Soc. Exp. Biol. Med. 136:1971;1045.
41. Johnson P., Smillie L. B. The amino acid sequence and predicted structure of Streptomyces griseus protease A. FEBS Letters. 47:1974;1-6.
42. Jurasek L., Carpenter M. R., Smillie L. B., Gertler A., Levy S., Ericsson H. L. Amino acid sequence of Streptomyces griseus protease B, a major component of pronase. Biochem. Biophys Res. Commun. 61:1974;1095-1100.
43. Kato I., Schrode J., Wilson K. A., Laskowski M., Jr. Evolution of Proteinase Inhibitors. XXIIIrd Annual Colloquium, Protides of the Biological Fluids. 1976.
44. Kato, I. Schrode, J. Kohr, J. Laskowski, M. Jr, 1987, Evolution of Avian Ovomucoids, Regulatory Proteolytic Enzymes and Their Inhibitors, 47, 197, 201.
45. Kato I., Schrode J., Kohr J., Laskowski M., Jr. Chicken ovomucoid: determination of its amino acid sequence, determination of the trypsin reactive site, and preparation of all three of its domains. Biochemistry. 26:1987;193-201.
46. Kellis J. T. Jr, Nyberg K., Sali D., Fersht A. R. Contribution of hydrohobic interactions to protein stability. Nature. 333:1988;784-786.
47. Kellis J. T. Jr, Nyberg K., Fersht A. R. Energetics of complementary side-chain packing in a protein hydrophobic core. Biochemistry. 28:1989;4914-4922.
48. Kojima S., Nishiyama Y., Kumajai I., Miura K. Inhibition of subtilisin BPN' by reactive site P1 mutants of Streptomyces subtilisin inhibitor. J. Biochem. 109:1991;377-382.
49. 18in the reactive site of turkey ovomucoid third domain converts it into a strong inhibitor of Glu -specific S treptomyces g riseus P roteinase (GluSGP). J. Biol. Chem. 266:1991;10727-10730.
50. Lai E. C., Stein J. P., Catterall J. F., Woo S. L. C., Mace M. L., Means A. R., O'Malley B. W. Molecular structure and flanking nucleotide sequences of the natural chicken ovomucoid gene. Cell. 18:1979;829-842.
51. Laskowski M., Jr. Protein inhibitors of serine proteinases-mechanism and classification. Friedman M. Nutritional and Toxicological Significance of Enzyme Inhibitors in Food. 1986;Plenum Pubs, New York.
52. Laskowski M., Jr, Kato I. Protein inhibitors of proteinases. Annu. Rev. Biochem. 49:1980;593-626.
53. Laskowski M., Jr, Tashiro M., Empie M. W., Park S. J., Kato I., Ardelt W., Wieczorek M. Relationship between the amino acid sequence and inhibitory activity of protein inhibitors of proteinases. Katunama N., et al. Proteinase Inhibitors: Medical and Biological Aspects. 1983;Japan Scientific Society Press, Tokyo/Springer Verlag, Berlin.
54. Laskowski M., Jr, Kato I., Ardelt W., Cook J., Denton A., Empie M. W., Kohr W. J., Park S. J., Parks K., Schatzley B. L., Schoenberger O. L., Tashiro M., Vichot G., Whatley H. E., Wieczorek A., Wieczorek M. Ovomucoid Third Domains from 100 avian species. Isolation, Sequence and hypervariability of enzyme-inhibitor contact residues. Biochemistry. 26:1987;202-221.
55. Laskowski M., Jr, Kato I., Kohr W. J., Park S. J., Tashiro M., Whatley H. E. Positive Darwinian selection in evolution of protein inhibitors of serine proteinases. Cold Spring Harbor Symp Quant. Biol. 52:1988;545-553.
56. Laskowski M., Jr, Park S. J., Tashiro M., Wynn R. Design of highly specific inhibitors of serine proteinases. Hutchens T. W. Protein Recognition of Immobilized Ligands, UCLA Symposia on Molecular and Cellular Biology, New Series, 80. 1989;Alan R. Liss, Inc. New York.
57. Laskowski M., Jr, Apostol I., Ardelt W., Cook J., Giletto A., Kelly C. A., Lu W., Park S. J., Qasim M. A., Whatley H. E., Wieczorek A., Wynn R. Amino acid sequences of ovommucoid third domain from 25 additional species of birds. J. Protein Chem. 9:1990;715-725.
58. Lee B. Estimation of the maximum change in stability of globular proteins upon mutation of a hydrophobic residue to another of smaller size. Protein Sci. 2:1993;733-738.
59. Levitt M. a simplified representation of protein conformations for rapid simulation of protein folding. J. Mol. Biol. 104:1976;59-107.
60. Lin, T. Y. 1986, Detailed characterization of ovomucoid third domains and of their interaction with enzymes. Ph. D. thesis, Purdue University, West Lafayette, IN, U.S.A.
61. Lu, W. 1994, Energetics of the interactions of ovomucoid third domain variants with different serine proteinases. Ph.D. thesis, Purdue University, West Lafayette, IN, U.S.A.
62. 1residues, The Protein Society, San Diego.
63. 18turkey ovomucoid third domain inhibits human furin. J. Biol. Chem. 268:1993a;14583-14585.
64. 1cavities in serine proteinases. Protein Sci. 2:1993b;122.
65. March, C. J. 1980, Multiple domain Kazal inhibitors. PhD thesis, Purdue University, West Lafayette, IN, USA.
66. Matsumura M., Becktel W. J., Matthews B. W. Hydrophobic stabilization in T4 lysozyme determined directly by multiple substitutions of Ile3. Nature. 334:1988;406-410.
67. Matthews B. W. Structural and genetic analysis of protein folding and stability. Curr. Opin. Struct. Biol. 3:1993;589-593.
68. Maurer R., Meyer B. J., Ptashne M. Gene regulation at the right operator (OR) of bacteriophage γ, I. OR3 and autogenous negative control by repressor. J. Mol. Biol. 139:1980;147-161.
69. Molina M. A., Marino C., Oliva B., Avilés F. X., Querol E. C-tail valine is a key residue for stabilization of complex between potato inhibitor and carboxypeptidase A. J. Biol. Chem. 269:1994;21467-21472.
70. *). J. Mol. Biol. 220:1991;739-755.
71. Nakamaye K. L., Eckstein F. Inhibition of restriction endomuclease Nci I cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis. Nucl. Acids Res. 14:1986;9679-9698.
72. Nienaber V., Breddam K., Birktoft J. A glutamic acid specific serine protease utilizes a novel histidine triad in substrate binding. Biochemistry. 32:1993;11469-11475.
73. Nilsson B., Abrahmsén L. Fusions to staphylococcal protein A. Methods Enzymol. 185:1990;144-161.
74. Papamokos E., Weber E., Bode W., Huber R., Empie M. W., Kato I., Laskowski M., Jr. Crystallographic refinement of Japanese quail ovomucoid, a Kazal-type inhibitor, and model building studies of complexes with serine proteases. J. Mol. Biol. 158:1982;515-537.
75. Park, S. J. 1985, Effect of amino acid replacements in ovomucoid third domains upon their association with serine proteinases. PhD thesis, Purdue University, West Lafayette, IN, USA.
76. 1residues in serine proteinase inhibitors undergo large p K shifts on complex formation. J. Biol. Chem. 270:1995;27419-27422.
77. Radzicka A., Wolfenden R. Comparing the polarities of the amino acids: side-chain distribution coefficients between the vapor phase cyclohexane, 1-octanol, and neutral aqueous solution. Biochemistry. 27:1988;1664-1670.
78. Randall L. L., Hardy S. J. S. Correlation of competence for export with lack of tertiary structure of the mature species: a study in vivo of maltose-binding protein in E. coli. Cell. 46:1986;921-928.
79. Read R. J., James M. N. G. Introduction to the protein inhibitors: X-ray crystallography. Barrett A. J., Salvesen G. Proteinase Inhibitors. 1986;Elsevier Science Publishers B.V. Amsterdam.
80. Read R. J., Fujinaga M., Sielecki A. R., James M. N. G. Structure of the complex of Streptomyces griseus protease B and the third domain of the turkey ovomucoid inhibitor at 1.8 Å resolution. Biochemistry. 22:1983;4420-4433.
81. Rhodes M. B., Bennet N., Feeney R. E. The trypsin and chymotrypsin inhibitors from avian egg whites. J. Biol. Chem. 235:1960;1686-1693.
82. Sandberg W. S., Terwilliger T. C. Energetics of repacking a protein interior. Proc. Natl Acad. Sci. USA. 88:1991;1706-1710.
83. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA. 74:1977;5463-5467.
84. Schecter I., Berger A. On the size of the active site in proteases I. Papain. Biochem. Biophys. Res. Commun. 27:1967;157-162.
85. Schellenberger V., Braune K., Hofmann H., Jakubke H. The specificity of chymotrypsin. Eur. J. Biochem. 199:1991;623-636.
86. Serrano L., Kellis J. T., Jr, Cann P., Matouschek A., Fersht A. R. The folding of an enzyme. II. Substructure of Barnase and the contribution of different interactions of protein stability. J. Mol. Biol. 224:1992;783-804.
87. Shortle D., Stites W. E., Meeker A. K. Contributions of the large hydrophobic amino acids to the stability of staphylococcal nuclease. Biochemistry. 29:1990;8033-8041.
88. Stein J. P., Catterall J. F., Woo S. L. C., Means A. R., O'Malley B. W. Molecular cloning of ovomucoid gene sequences from partially purified ovomucoid messenger RNA. Biochemistry. 17:1978;5763-5772.
89. Tamura A., Mitsushita M., Naito A., Kojima S., Miura K.-I., Akasaka K. Dynamics of the three methionyl side chains of Streptomyces subtilisin inhibitor. Deuterium NMR studies in solution and in the solid state. Protein Sci. 5:1996;127-139.
90. Tanford C. Contribution of hydrophobic interactions to the stability of the globular conformation of proteins. J. Am. Chem. Soc. 84:1962;4240-4247.
91. Taylor J. W., Schmidt W., Cosstick R., Okruszek A., Eckstein F. The use of phosphorothioate-modified DNA in restriction enzyme reactions to prepare nicked DNA. Nucl. Acids Res. 13:1985;8749-8764.
92. Thomson J., Ratnaparkhi G. S., Varadarajan R., Sturtevant J. M., Richards F. M. Thermodynamic and structural consequences of changing a sulfur atom to a methylene group in the M13Nle mutation in Ribonuclease-S. Biochemistry. 33:1994;8587-8593.
93. Vieira J., Messing J. Production of single-stranded plasmid DNA. Methods Enzymol. 153:1987;3-11.
94. Warne, N. W. 1990, Total chemical synthesis of turkey ovomucoid third domain and an HLE specific inhibitor. Ph.D. thesis, Purdue University, West Lafayette, IN, U.S.A.
95. Weber E., Papamokos E., Bode W., Huber R., Kato I., Laskowski M., Jr. Crystallization, crystal structure analysis and molecular model of the third domain of Japanese quail ovomucoid, a Kazal type inhibitor. J. Mol. Biol. 149:1981;109-123.
96. Wells J. A. Additivity of mutational effects in proteins. Biochemistry. 29:1990;8509-8517.
97. Wieczorek M., Laskowski M., Jr. Formation of covalent hybrids from amino-terminal and carboxy-terminal fragments of two ovomucoid third domains. Biochemistry. 22:1983;2630-2636.
98. Wieczorek M., Park S. J., Laskowski M., Jr. Covalent hybrids of ovomucoid third domains made from one synthetic and one natural peptide chain. Biochem. Biophys. Res. Commun. 144:1987;499-504.
99. Wynn, R. 1990, Design of a specific human leukocyte elastase inhibitor based on ovomucoid third domains. Ph.D. thesis, Purdue University, West Lafayette, IN, U.S.A.
100. Yoshida N., Tsuruyama S., Nagata K., Hirayama K., Noda K., Makisumi S. Purification and characterization of an acidic amino acid specific endopeptidase of Streptomyces griseus obtained from a commercial preparation (Pronase). J. Biochem. 104:1988;451-456.